The current study sought to determine whether urinary DKK3 (uDKK3) is a potential biomarker in an ADPKD real-world scenario and whether it can improve the predictive accuracy of currently used clinical criteria. The gene discussed is DKK3; the disease is autosomal dominant polycystic kidney disease.